Structural Studies of Amyloid Proteins at the Molecular Level.
暂无分享,去创建一个
[1] David Baker,et al. Cooperative hydrogen bonding in amyloid formation , 2007, Protein science : a publication of the Protein Society.
[2] D. Walsh,et al. Amyloid β-Protein Fibrillogenesis , 1997, The Journal of Biological Chemistry.
[3] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] Frank Baumann,et al. Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.
[5] D. Eisenberg,et al. Atomic structures suggest determinants of transmission barriers in mammalian prion disease. , 2011, Biochemistry.
[6] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[7] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[8] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[9] Heather T. McFarlane,et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.
[10] Peter T. Lansbury,et al. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .
[11] G. Irvine,et al. Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity , 2001, Journal of neurochemistry.
[12] L. Pauling,et al. Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets. , 1951, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[14] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[15] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[16] B. Meier,et al. Atomic-resolution three-dimensional structure of HET-s(218-289) amyloid fibrils by solid-state NMR spectroscopy. , 2010, Journal of the American Chemical Society.
[17] Robert A. Grothe,et al. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Baker,et al. The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Radford,et al. Globular Tetramers of β2-Microglobulin Assemble into Elaborate Amyloid Fibrils , 2009, Journal of molecular biology.
[20] Fred H. Gage,et al. In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.
[21] D. Eisenberg,et al. Designed amyloid fibers as materials for selective carbon dioxide capture , 2013, Proceedings of the National Academy of Sciences.
[22] Richard D. Leapman,et al. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.
[23] David Eisenberg,et al. Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease* , 2010, The Journal of Biological Chemistry.
[24] K. Lasker,et al. Peptide dimer structure in an Aβ(1–42) fibril visualized with cryo-EM , 2015, Proceedings of the National Academy of Sciences.
[25] Richard D. Leapman,et al. Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.
[26] G. Glenner,et al. X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[27] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[28] Sara Linse,et al. Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils. , 2016, Journal of the American Chemical Society.
[29] G. J. Raymond,et al. The most infectious prion protein particles , 2005, Nature.
[30] Peter Güntert,et al. Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril , 2016, Proceedings of the National Academy of Sciences.
[31] M. Fändrich,et al. Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. , 2012, Journal of molecular biology.
[32] K. Bailey,et al. The X-ray interpretation of denaturation and the structure of the seed globulins. , 1935, The Biochemical journal.
[33] Roger Cooke,et al. Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.
[34] J. Stroud,et al. Antiparallel Triple-strand Architecture for Prefibrillar Aβ42 Oligomers* , 2014, The Journal of Biological Chemistry.
[35] R. Leapman,et al. Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure , 2009, Proceedings of the National Academy of Sciences.
[36] Markus J Buehler,et al. Nanomechanics of functional and pathological amyloid materials. , 2011, Nature nanotechnology.
[37] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[38] Ronald Wetzel,et al. A serendipitous survey of prediction algorithms for amyloidogenicity. , 2013, Biopolymers.
[39] R. Glockshuber,et al. Atomic-Resolution Three-Dimensional Structure of Amyloid β Fibrils Bearing the Osaka Mutation , 2014, Angewandte Chemie.
[40] R. Tycko,et al. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.
[41] D. Eisenberg,et al. Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity , 2016, eLife.
[42] H. Wolfson,et al. Shape complementarity at protein–protein interfaces , 1994, Biopolymers.
[43] David Eisenberg,et al. In Brief , 2009, Nature Reviews Neuroscience.
[44] M. Benson,et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[45] David Eisenberg,et al. Towards a Pharmacophore for Amyloid , 2011, PLoS biology.
[46] D. Eisenberg,et al. A method to identify protein sequences that fold into a known three-dimensional structure. , 1991, Science.
[47] Ruth Nussinov,et al. Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s , 2015, Nature Structural &Molecular Biology.
[48] Scott J. Hultgren,et al. Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.
[49] E. Haas,et al. A folding transition underlies the emergence of membrane affinity in amyloid-β. , 2013, Physical chemistry chemical physics : PCCP.
[50] R. Melki,et al. Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells. , 2012, Biophysical journal.
[51] Jimin Pei,et al. Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels , 2012, Cell.
[52] Atanas V Koulov,et al. Functional Amyloid Formation within Mammalian Tissue , 2005, PLoS biology.
[53] David Eisenberg,et al. β2-microglobulin forms 3D domain-swapped amyloid fibrils with disulfide linkages , 2010, Nature Structural &Molecular Biology.
[54] D. Eisenberg,et al. A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. , 2016, Cancer cell.
[55] Michele Vendruscolo,et al. Atomic structure and hierarchical assembly of a cross-β amyloid fibril , 2013, Proceedings of the National Academy of Sciences.
[56] David Eisenberg,et al. Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.
[57] A. Kishimoto,et al. beta-Helix is a likely core structure of yeast prion Sup35 amyloid fibers. , 2004, Biochemical and biophysical research communications.
[58] S. Scheres,et al. How cryo-EM is revolutionizing structural biology. , 2015, Trends in biochemical sciences.
[59] David Eisenberg,et al. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.
[60] D. Eisenberg,et al. Toward the Atomic Structure of PrPSc. , 2017, Cold Spring Harbor perspectives in biology.
[61] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[62] E. L. Guenther,et al. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS , 2013, Proceedings of the National Academy of Sciences.
[63] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] P. Westermark,et al. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. , 1991, Biochemical and biophysical research communications.
[65] D. Eisenberg,et al. Toxic fibrillar oligomers of amyloid-β have cross-β structure , 2012, Proceedings of the National Academy of Sciences.
[66] E. Kandel,et al. A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.
[67] D. Raleigh,et al. Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics , 2016, eLife.
[68] Charles D. Schwieters,et al. Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.
[69] Ronald Wetzel,et al. Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.
[70] Young-Ho Lee,et al. Cold denaturation of α-synuclein amyloid fibrils. , 2014, Angewandte Chemie.
[71] D. Holtzman,et al. Trans-cellular Propagation of Tau Aggregation by Fibrillar Species* , 2012, The Journal of Biological Chemistry.
[72] A. Mehta,et al. Kinetic intermediates in amyloid assembly. , 2014, Journal of the American Chemical Society.
[73] M. Sunde,et al. Functional amyloid: widespread in Nature, diverse in purpose. , 2014, Essays in biochemistry.
[74] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[75] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[76] D. Otzen. Functional amyloid , 2010, Prion.
[77] J. Snyder,et al. Facial symmetry in protein self-assembly. , 2008, Journal of the American Chemical Society.
[78] L. Serpell,et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.
[79] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[80] A. Cohen,et al. Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins , 1959, Nature.
[81] M. Goedert,et al. A Century of Alzheimer's Disease , 2006, Science.
[82] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[83] David Eisenberg,et al. Molecular basis for amyloid-β polymorphism , 2011, Proceedings of the National Academy of Sciences.
[84] R. Tycko. Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.
[85] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[86] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[87] Nicholas K. Sauter,et al. Structure of the toxic core of α-synuclein from invisible crystals , 2015, Nature.
[88] D. Eisenberg,et al. Crystal Structures of IAPP Amyloidogenic Segments Reveal a Novel Packing Motif of Out-of-Register Beta Sheets. , 2016, The journal of physical chemistry. B.
[89] H. Scheraga,et al. Structure of beta-sheets. Origin of the right-handed twist and of the increased stability of antiparallel over parallel sheets. , 1982, Journal of molecular biology.
[90] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[91] Christopher M Dobson,et al. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.
[92] Lawrence Rajendran,et al. The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.
[93] David Eisenberg,et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.
[94] J. Stroud. The zipper groups of the amyloid state of proteins , 2013, Acta crystallographica. Section D, Biological crystallography.
[95] David Eisenberg,et al. Molecular mechanisms for protein-encoded inheritance , 2009, Nature Structural &Molecular Biology.
[96] A. Fagan,et al. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease , 2009, Nature.
[97] R. Katzman.,et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.
[98] Alexander K. Buell,et al. The physical chemistry of the amyloid phenomenon: thermodynamics and kinetics of filamentous protein aggregation. , 2014, Essays in biochemistry.
[99] S. Prusiner,et al. A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.
[100] D. Eisenberg,et al. Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates , 2012, Proceedings of the National Academy of Sciences.